INITIAL EVALUATION

---

Proper evaluation of prostate cancer—or even the suspicion of it—begins with a detailed medical history and a focused physical examination.

It’s important to understand that early prostate cancer rarely causes noticeable symptoms. Many men feel completely normal at the time of diagnosis.

However, as men age (typically after 40–50), benign prostate enlargement becomes more common and can lead to urinary symptoms such as:

• Slower urine stream
• Increased frequency of urination
• Waking at night to urinate

While these symptoms are not typically caused by prostate cancer, they are still important to evaluate as part of the overall picture.

A comprehensive evaluation also includes a careful review of personal and family history.

Key factors include:

• Family history of prostate cancer, especially in first-degree relatives
• History of other cancers within the family
• Prior prostate-related testing or procedures

These details help guide decision-making and determine the level of concern.

A digital rectal examination (DRE) remains an important part of prostate evaluation and should not be overlooked.

While it may not detect every cancer, it can identify abnormalities that require further investigation.

The PSA (Prostate-Specific Antigen) blood test is a key tool—but it is often misunderstood.

• PSA is not a definitive cancer test
• Benign conditions frequently cause elevated PSA levels
• Prostate cancer can still be present with a “normal” PSA

Tracking PSA trends over time is often more valuable than a single result.

In some cases, additional blood or urine tests may be recommended—particularly for men who have had:

• Prior biopsies
• Previous prostate MRI imaging
• 
  

If prostate cancer is suspected, a prostate MRI is strongly recommended before biopsy.

MRI allows us to:

• Identify areas that may be suspicious for cancer
• Precisely target those areas during biopsy
• Improve accuracy of diagnosis
• 
  

Ultimately, a prostate biopsy is required to determine:

• Whether cancer is present
• The grade and aggressiveness of the cancer

Even with modern imaging, random (systematic) biopsy samples are often still necessary alongside targeted biopsy.

Important: A normal MRI does not rule out prostate cancer.
In most cases where suspicion remains, a biopsy is still recommended.

The goal of the initial evaluation is simple:
Get the most accurate information possible—so the right decisions can be made with confidence.

At Jurige Prostate Care, each step of the process is guided by experience, precision, and a focus on avoiding unnecessary treatment while not missing clinically significant disease.